2024
|
Invention
|
Pvrig binding protein, bispecific antibody, and use. Provided are a PVRIG binding protein, a bisp... |
|
Invention
|
Use of anti-pd-l1/cd47 bispecific antibody in combination therapy. Use of an anti-PD-L1/CD47 bisp... |
|
Invention
|
Use of anti-pd-1 antibody combined with chemotherapeutic agent in treatment of tumors. Provided i... |
|
Invention
|
Anti-tnfr2 antibody and use thereof. The present invention belongs to the field of biomedicine, a... |
|
Invention
|
Fusion protein and use thereof. A fusion protein and a use thereof. The fusion protein comprises ... |
|
Invention
|
Application of anti-frα antibody-drug conjugate in treatment of diseases. An application of an an... |
|
Invention
|
Bispecific antibody targeting tumor-associated antigen and cd28, and use of bispecific antibody. ... |
|
Invention
|
Anti-il-4rα antibody formulation, preparation method therefor, and use thereof. An anti-IL-4Rα an... |
|
Invention
|
4-1bb binding protein. Provided is a 4-1BB binding protein, which can specifically bind to 4-1BB,... |
|
Invention
|
Anti-angptl3 antibody and use thereof. Provided are an anti-ANGPTL3 antibody and a use thereof. T... |
|
Invention
|
Liquid formulations comprising high concentrations humanized antibodies for treating il-6 related... |
|
Invention
|
Gel buffer solution and method used for capillary electrophoresis. A method and a gel buffer solu... |
|
Invention
|
Antibody nasal spray targeting coronavirus and use thereof. An antibody nasal spray targeting a c... |
|
Invention
|
Compound preparation and use thereof. Provided is a compound preparation and a use thereof. The c... |
|
Invention
|
Use of anti-ox40 antibody in treatment of inflammations or immune diseases. A use of an anti-OX40... |
|
Invention
|
Stable anti-vegf antibody formulation. Provided is a stable anti-VEGF antibody formulation. The a... |
|
Invention
|
Anti-cd93 antibody and use thereof. Provided in the present invention are an anti-CD93 antibody o... |
|
Invention
|
Compound preparation and use thereof. A compound preparation. The compound preparation contains a... |
2023
|
Invention
|
Antibody preparation targeting coronavirus and use thereof. The present invention belongs to the ... |
|
Invention
|
Coronavirus multivalent vaccine and use thereof. The present invention provides a coronavirus mul... |
|
Invention
|
Fusion protein for preventing or treating coronavirus infection, spike protein nanoparticle, and ... |
|
Invention
|
Combined use of anti-tigit antibody and anti-ctla-4 antibody in treating tumor. The present inven... |
|
Invention
|
Anti-nectin-4 antibody and use thereof. Provided are an anti-Nectin-4 antibody and the use thereo... |
|
Invention
|
Anti-nectin-4 antibody drug conjugate and use thereof. An anti-Nectin-4 antibody drug conjugate a... |
|
Invention
|
Anti-nectin-4 antibody, and antibody-drug conjugate and use thereof. An anti-Nectin-4 antibody, a... |
|
Invention
|
Method for treating solid tumor. The present invention provides a method for treating a solid tum... |
|
Invention
|
Anti-cldn18.2 antibody, and antibody-drug conjugate and use thereof. The present invention belong... |
|
Invention
|
Method for treating her2-positive solid tumor. Disclosed is a method for treating a HER2-positive... |
|
Invention
|
Application of anti-vista antibody in combination drug. The present invention provides a composit... |
|
Invention
|
Anti-cd28 antibody and use thereof. Disclosed are an anti-CD28 antibody or an antigen-binding fra... |
|
Invention
|
Use of antibody targeting coronavirus in preventing, treating, or ameliorating covid-19. Provided... |
2022
|
Invention
|
Anti-frα antibody, and antibody-drug conjugate and use thereof. An anti-FRα antibody and an antib... |
|
Invention
|
Antibody-drug conjugate and application thereof. Disclosed in the present invention are an antibo... |
|
Invention
|
Anti-b7-h3 antibody and application thereof. Provided are an anti-B7-H3 antibody and an applicati... |
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; Injectable pharmaceutical preparations f... |
|
Invention
|
Fusion protein and spike protein nanoparticle for preventing or treating coronavirus infections, ... |
|
Invention
|
Use of anti-pd-l1/cd47 bispecific antibody in treatment of diseases. Provided is the use of an an... |
|
Invention
|
Integrin gpiib/iiia antagonist and application thereof in combination with anti-vegf antibody. Di... |
|
Invention
|
Application of anti-ox40 antibody in combined drug. Disclosed is an application of an anti-OX40 a... |
|
Invention
|
Antibody targeting coronavirus and use thereof. Provided are a bispecific antibody, a single-doma... |
|
Invention
|
Drug conjugate and use thereof. A drug conjugate, such as an antibody drug conjugate, and the use... |
|
Invention
|
Anti-sirpα antibody and use thereof. An anti-SIRPα antibody or an antigen-binding fragment thereo... |
|
Invention
|
Anti-cd73 antibody and use thereof. Provided in the present invention are an anti-CD73 antibody a... |
|
Invention
|
Application of anti-pd-1 antibody. Provided are an anti-PD-1 antibody and an application thereof ... |
|
Invention
|
Coronavirus antibody and use thereof. Provided in the present invention are an antibody specifica... |
|
Invention
|
Anti-vista antibody and application thereof. The present invention provides an anti-VISTA antibod... |
|
Invention
|
Application of anti-tigit antibody in drug combination. The present invention provides a combinat... |
2021
|
Invention
|
Anti-vegf antibody formulation. Provided is an anti-VEGF antibody formulation. The antibody formu... |
2019
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of cancer, tumor, autoimmune disease... |
|
G/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations; drugs for medical purposes; bi... |